Home › Vertex wins big with approval of new cystic fibrosis drug
 

Keywords :   


Vertex wins big with approval of new cystic fibrosis drug

2015-07-02 19:21:58| Biotech - Topix.net

The Food and Drug Administration has approved a potential blockbuster drug by Boston-based Vertex Pharmaceuticals to treat cystic fibrosis that is expected to make the company profitable within three years. The drug, called Orkambi, is a combination of the company's existing drug, Kalydeco, with a new drug which makes it usable by about four times as many patients with the disease.

Tags: big drug approval wins

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
30.06Atlantic Tropical Weather Outlook
30.06Eastern North Pacific Tropical Weather Outlook
30.06Hurricane Beryl Graphics
30.06Hurricane Beryl Public Advisory Number 6A
30.06Summary for Hurricane Beryl (AT2/AL022024)
30.06Hurricane Beryl Graphics
30.06Hurricane Beryl Wind Speed Probabilities Number 6
30.06Hurricane Beryl Public Advisory Number 6
More »